Skip to main content
TipRanks
Go Ultimate75% OFF

Leef Brands (LEEF) AI Stock Analysis

12 Followers
TSE:LEEF

Leef Brands

(CNQX:LEEF)

Select Model
Rating:45Neutral
Price Target:CAD 0.22â–¼(-2.27% Downside)
Action:reiterated
Date:10/31/26

The overall score of 45 reflects a high-risk, early-stage turnaround situation. The company's extremely weak financial performance and bearish technicals are significant drags. However, these are partially offset by a credible strategic plan outlined in the earnings call, which includes a strengthened balance sheet, operational milestones, and a clear path to improved margins from vertical integration. The primary risk remains the company's ability to execute this plan and achieve sustainable profitability before its cash reserves are depleted.

Positive Factors
Margin expansionThe sharp improvement in gross profit and margin indicates better product mix and extraction performance, particularly when using owned biomass. If sustained through vertical integration, higher margins can strengthen unit economics, support reinvestment, and improve the company’s path toward durable profitability.
Negative Factors
Persistent losses and revenue declineThe combination of falling trailing revenue, sizable net losses, and negative EBITDA shows that the business has not yet established sustainable profitability. Until improved margins consistently offset operating costs, earnings remain vulnerable to changes in volume, product mix, and market conditions.

Leef Brands (LEEF) vs. iShares MSCI Canada ETF (EWC)

-40%-30%-20%-10%0%10%20%30%TSE:LEEF-8.33%EWC+18.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 31.57M
Dividend Yield
―
Average Volume (3M)
91.21K
Price to Earnings (P/E)
-1.7
Beta (1Y)
0.00
Revenue Growth
―
EPS Growth
―
Country
Canada
Employees
81
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Leef Brands Business Overview & Revenue Model

Company Description

Leef Brands Inc. operates as a U.S.-based manufacturer of branded cannabis products. The company's operations are divided into two main divisions: Wholesale Concentrates and Retail. Its Wholesale Concentrates segment manages the complete production c...

How the Company Makes Money

Leef Brands primarily makes money by selling cannabis products into legal state markets through (1) branded product sales and (2) contract/white-label manufacturing and product supply for third parties. Revenue is generated when products are sold to...

Leef Brands Earnings Call Summary

Earnings Call Date:Aug 06, 2026(Q2-2026)|% Change Since:-15.38%|Next Earnings Date:May 01, 2025
Earnings Call SentimentPositive

The call portrayed a company in transition: Q2 showed temporary softness with a 16% revenue decline, negative adjusted EBITDA for the quarter and volume pullbacks due to running purchased biomass. Offsetting those near-term headwinds are strong strategic and operational developments — an oversubscribed capital raise (~$14.2M YTD), completion of the largest harvest with exceptionally high-quality oil (95% THC, passed CAT4), acquisition of HIMALAYA (added ~$1M revenue), materially improved gross profit (+62% YoY) and margin expansion (33% vs 17% prior year), a growing acreage footprint targeting 180 acres in 2027, new processing capacity, and active regulatory and customer engagement positioning the company for interstate and export opportunities. Overall, management presented these negatives as temporary and solvable via vertical integration and recent investments.

Positive Updates

Gross Profit and Margin Expansion
Gross profit increased 62% year-over-year to $2.4 million and gross margin nearly doubled to 33% from 17% a year ago, driven by mix shift to higher-margin hydrocarbon products and improved extraction performance when running owned biomass.

Negative Updates

Quarterly Revenue and Volume Decline
Net revenue declined 16% year-over-year to $7.3 million (from $8.7 million) and unit volumes were down approximately 20%, reflecting a deliberate pullback on purchased biomass and softer California wholesale demand.

Company Guidance

The company guided that its Q2 softness was temporary and tied to running third‑party biomass, with revenue down 16% to $7.3M, unit volumes down ~20% partially offset by a ~5% ASP improvement, and adjusted EBITDA of negative $631k (first half adjusted EBITDA still +$1.7M vs -$2.1M YoY), while gross profit rose 62% to $2.4M and gross margin nearly doubled to 33% from 17% as hydrocarbon products became the largest revenue category; operationally Leef completed an oversubscribed $9.3M financing, raised roughly $9M in H1 plus $5.2M in July (≈$14.2M YTD) to buy a processing facility, acquired Himalaya (≈$1M contributed in the partial quarter), filed DEA registration applications, finished its largest harvest with the first several hundred liters in July testing ~95% THC / ~99% total cannabinoids and passing CA CAT4 screens, and expects acreage to reach ~122 acres this fall (an 88% YoY increase) en route to operating the full 180‑acre permit in 2027 (plus contracted/partnered 21‑acre blocks), inventory grew to $7.1M (WIP $4.2M), cash was $5M (from $2.2M), working capital turned to a surplus of $8.7M, and management reiterated that running its own biomass historically drives gross margins toward ~50% (vs ~33% on bought material), with margin and distillate volume recovery expected in late Q3 and into Q4 and longer‑term cost targets like distillate < $0.50/gram (vs CA sell price ~$1/g and potential out‑of‑state prices of $3.50–$12/g) implying very high incremental margins.

Leef Brands Financial Statement Overview

Summary

Financial health is critically weak. The company has persistent net losses, negative stockholders' equity, and negative operating cash flow. While gross margin improved to 31.5% and total debt was reduced, the core operations are not self-sustaining, posing a high risk.

Income Statement

18Very Negative

Balance Sheet

8Very Negative

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2025Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue34.77M30.75M34.79M28.50M30.61M27.00M
Gross Profit12.62M7.62M10.48M8.94M10.02M9.55M
EBITDA-11.08M-17.39M-10.44M-14.26M-33.41M-18.89M
Net Income-18.32M-17.63M-17.63M-24.62M-34.97M-28.92M
Balance Sheet
Total Assets41.85M41.27M36.40M42.98M44.00M61.93M
Cash, Cash Equivalents and Short-Term Investments5.76M887.89K2.19M2.73M6.41M3.31M
Total Debt12.31M24.14M12.60M23.15M20.38M10.91M
Total Liabilities47.60M54.35M44.67M55.41M43.15M34.19M
Stockholders Equity-5.75M-13.08M-8.27M-12.43M-2.80M23.94M
Cash Flow
Free Cash Flow-122.02K-7.43M-1.49M-7.32M-7.42M-6.44M
Operating Cash Flow1.50M-4.01M-336.89K-1.05M187.82K-6.32M
Investing Cash Flow-1.08M-3.01M-749.22K-6.27M-7.28M2.23M
Financing Cash Flow4.01M4.76M545.20K3.63M10.38M49.69K

Leef Brands Technical Analysis

Technical Analysis SentimentNegative
Last Price0.22

Price Trends

50DMA0.24Negative
100DMA0.26Negative
200DMA0.23Negative

Market Momentum

MACD-0.00Negative
RSI47.02Neutral
STOCH39.39Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEEF, the sentiment is Negative. The current price of 0.22 is above the 20-day moving average (MA) of 0.22, below the 50-day MA of 0.24, and below the 200-day MA of 0.23, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 47.02 is Neutral, neither overbought nor oversold. The STOCH value of 39.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LEEF.

Leef Brands Risk Analysis

Leef Brands disclosed 61 risk factors in its most recent earnings report. Leef Brands reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Leef Brands Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:LEEF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:LEEFTSE:LEEF45NeutralCAD 67.22M-1.73206.83%―――
TSE:JUSHTSE:JUSH43NeutralCAD 109.84M-1.4040.14%―5.37%17.78%
TSE:CWEBTSE:CWEB42NeutralCAD 65.11M-0.87-139.31%―-9.90%-35.35%
TSE:AYR.ATSE:AYR.A40NeutralCAD 18.10M-0.03-74.75%―――
TSE:PLTHTSE:PLTH39UnderperformCAD 38.56M-1.13-59.17%―-15.64%71.65%

* Healthcare Sector Average

Performance Comparison

0%200%400%600%800%TSE:LEEFTSE:JUSHTSE:CWEBTSE:AYR.ATSE:PLTHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:LEEF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:LEEFLeef Brands Inc0.22-0.02-10.20%
TSE:JUSHJushi Holdings Inc0.550.023.77%
TSE:CWEBCharlotte's Web Holdings (OTC)0.240.1071.43%
TSE:AYR.AAyr Wellness Inc.0.150.000.00%
TSE:PLTHPlanet 13 Holdings, Inc.0.12-0.10-46.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026